Ehouse Global, Inc.

OTC: EHOS · Healthcare · Biotechnology

PublicHQ San Diego, CIK 0001452580Reports USD

#863 of 1,394 Healthcare companies by revenue26th-percentile growth

EA Score

——

FH —DQ 8GM —SS 25

v0.1 · 25/100 weight · pillars only

↑ operating margin, listing tenure · ↓ disclosure history, return on assets

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$2.8M

Employees

Market cap

$10.1k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$1.0M$1.0M2011

Net income-$2.8M-$2.8M2014

Operating income-$346.3k-$346.3k2013

Total assets$5.8k$5.8k2014

Liabilities$1.1M$1.1M2014

Equity-$1.1M-$1.1M2014

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Ehouse Global, Inc. booked $1.0M in FY2011 revenue, contracting 24% year over year — slower than 74% of Healthcare companies we track, at a -274.7% net margin.

Peers · Healthcare

OneLife Technologies Corp.——Navidea Biopharmaceuticals, Inc.——VIA Pharmaceuticals, Inc.——Valeo Pharma Inc.——

Key facts

CEOJonathan Smith

SectorHealthcare

IndustryBiotechnology

HeadquartersSan Diego, null

ExchangeOTC: EHOS

Employees2

IPO date2013-07-03

Latest filings

8-K2015-05-20 10-Q2015-05-20 10-K2015-04-15 8-K2015-03-12 8-K2015-02-18 10-Q2014-11-14 8-K2014-09-04 10-Q2014-08-19

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.